Related Experiment Video
Updated: Feb 28, 2026

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
Mast Cell Infiltration in Human Brain Metastases Modulates the Microenvironment and Contributes to the Metastatic
Ananya Roy1,2, Sylwia Libard1, Holger Weishaupt1
1Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden.
Abstract:
Metastatic brain tumors continue to be a clinical problem, despite new therapeutic advances in cancer treatment. Brain metastases (BMs) are among the most common mass lesions in the brain that are resistant to chemotherapies, have a very poor prognosis, and currently lack any efficient diagnostic tests. Predictions estimate that about 40% of lung and breast cancer patients will develop BM. Despite this, very little is known about the immunological and genetic aberrations that drive tumorigenesis in BM. In this study, we demonstrate the infiltration of mast cells (MCs) in a large cohort of human BM samples with different tissues of origin for primary cancer. We applied patient-derived BM cell models to the study of BM cell-MC interactions. BM cells when cocultured with MCs demonstrate enhanced growth and self-renewal capacity. Gene set enrichment analyses indicate increased expression of signal transduction and transmembrane proteins related genes in the cocultured BM cells. MCs exert their effect by release of mediators such as IL-8, IL-10, matrix metalloprotease 2, and vascular endothelial growth factor, thereby permitting metastasis. In conclusion, we provide evidence for a role of MCs in BM. Our findings indicate MCs' capability of modulating gene expression in BM cells and suggest that MCs can serve as a new target for drug development against metastases in the brain.
Insights
Mast cells (MCs) promote brain metastasis (BM) growth and self-renewal by altering gene expression in tumor cells. Targeting MCs may offer a novel therapeutic strategy for brain metastases.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Brain metastases (BMs) are common, aggressive, and poorly understood, with limited treatment options.
- Current understanding of the immunological and genetic drivers of BM tumorigenesis is lacking.
- Mast cells (MCs) are implicated in various cancers, but their role in BMs is unclear.
Purpose of the Study:
- To investigate the infiltration and role of mast cells (MCs) in human brain metastases (BMs).
- To elucidate the mechanisms by which MCs interact with and influence BM cells.
- To identify potential therapeutic targets for managing BMs.
Main Methods:
- Analysis of MC infiltration in a large cohort of human BM samples.
- Utilized patient-derived BM cell models for co-culture experiments with MCs.
- Performed gene set enrichment analysis and mediator quantification.
Main Results:
- Demonstrated significant mast cell (MC) infiltration across diverse primary cancer origins in BMs.
- Co-culture of BM cells with MCs enhanced BM cell growth and self-renewal capacity.
- MCs release mediators (IL-8, IL-10, MMP-2, VEGF) that promote metastasis and modulate gene expression in BM cells.
Conclusions:
- Mast cells (MCs) play a significant role in the development and progression of brain metastases (BMs).
- MCs can modulate gene expression in BM cells, contributing to tumorigenesis.
- MCs represent a promising novel therapeutic target for treating brain metastases.
More Related Videos
05:02Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
07:24Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection
Published on: January 16, 2026
Related Concept Videos
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...